Cipro vs. Macrobid
See how Cipro and Macrobid compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Cipro treats a much wider range of infections than Macrobid, including kidney, bone, and respiratory infections, while Macrobid only treats bladder infections.
Both list nausea and diarrhea among their common side effects, but Cipro carries a boxed warning for tendon rupture and nerve damage that Macrobid does not.
Macrobid is generally the first choice for a simple bladder infection, while Cipro is usually saved for infections without safer treatment options.
Cipro vs. Macrobid Drug Summary
Cipro
Cipro (ciprofloxacin) is a fluoroquinolone antibiotic used for a wide range of bacterial infections, including complicated and uncomplicated UTIs, skin, bone, and respiratory infections. It is taken as a tablet every 12 hours, with the dose and length of treatment depending on the type of infection.
Macrobid
Macrobid (nitrofurantoin) is a urinary anti-infective used specifically for acute, uncomplicated bladder infections caused by E. coli or S. saprophyticus. It is taken as a capsule every 12 hours for 7 days and works only in the urinary tract, not for kidney infections or infections elsewhere in the body.
Cipro vs. Macrobid Side Effects
Cipro
Macrobid
Cipro vs. Macrobid Dosage
Cipro
Macrobid
| STAGE | DOSE | WHEN |
| Starting dose | 250 mg every 12 hours | At the start |
| Maximum dose | 750 mg every 12 hours | If needed |
| Dose changes | 2 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
Cipro
| STAGE | DOSE | WHEN |
| Starting dose | 250 mg every 12 hours | At the start |
| Maximum dose | 750 mg every 12 hours | If needed |
| Dose changes | 2 increases | As tolerated |
Macrobid
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
Cipro vs. Macrobid Indications
Cipro
Cipro is FDA-approved for a broad range of bacterial infections beyond the urinary tract, including skin, bone, joint, respiratory, and abdominal infections, plus specific uses like anthrax exposure and typhoid fever. Because of its boxed warning, current FDA guidance says it should be reserved for infections without safer alternative options, especially uncomplicated UTIs.
Complicated and uncomplicated UTIs
Chronic bacterial prostatitis
Skin, bone, and joint infections
Respiratory and abdominal infections
Macrobid
Macrobid is FDA-approved only for acute, uncomplicated UTIs (cystitis) caused by susceptible E. coli or S. saprophyticus, not for kidney infections or infections outside the bladder. Doctors also prescribe it off-label at a lower dose for long-term prevention of recurrent UTIs, though this use isn't FDA-approved.
Acute uncomplicated UTIs (cystitis)
Caused by E. coli or S. saprophyticus
Off-label: recurrent UTI prevention
Not approved for kidney infections
Cipro vs. Macrobid Pros and Cons
Cipro
Cipro's broad spectrum and ability to reach therapeutic blood levels make it useful for infections outside the bladder, such as kidney and bone infections. That same broad reach comes with a boxed warning for tendon and nerve damage that Macrobid does not carry, so it is generally reserved for infections without safer options.
Pros
Treats infections beyond the bladder, including kidney
Short 3-day course for uncomplicated UTIs
Reaches therapeutic levels in blood and tissue
Generic often costs $10 to $20 per course
Cons
Boxed warning: tendon rupture, nerve, and CNS effects
FDA says reserve for infections without other options
Interacts with many drugs, dairy, and antacids
Linked to increased risk of C. diff infection
Macrobid
Macrobid stays concentrated in urine and works well for uncomplicated bladder infections without much systemic drug exposure. It cannot treat kidney infections or infections outside the urinary tract, and it isn't safe for patients with reduced kidney function.
Pros
Still reliably effective against E. coli after decades
Minimal systemic absorption limits some side effects
Used long-term at low dose to prevent recurrent UTIs
No boxed warning for tendon or nerve damage
Cons
Only treats bladder infections, not kidney infections
Unsafe for patients with reduced kidney function
Rare but serious lung and liver toxicity long-term
Brand price often $80 to $200 per month
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.